BLI International, Inc. recalls Chlorpheniramine Maleate 4 mg tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Superpotent Drug: Stability failure for assay at 6 months test time-point.
- Products
-
- Chlorpheniramine Maleate 4 mg tablets
- Company
- BLI International, Inc.
- Where it was sold
-
Product was shipped to two private label customers ( OH & MO) as a final packaged product.
States: Missouri, Ohio
- Units affected
- 4,901 cases/24 count each case
- About this recall
- Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24